Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinomaYu‐Pei Chen, Jun Ma, Qing‐Mei He et al.|Cell Research|2020Cited by 483
Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and ChemoresistanceZi‐Qi Zheng, Ying Sun, Zhi‐Xuan Li et al.|Cancer Research|2020Cited by 138
Unraveling tumour microenvironment heterogeneity in nasopharyngeal carcinoma identifies biologically distinct immune subtypes predicting prognosis and immunotherapy responsesYu‐Pei Chen, Jun Ma, Jia‐Wei Lv et al.|Molecular Cancer|2021Cited by 99
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trialsJia‐Wei Lv, Yu‐Pei Chen, Junyan Li et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 82
Self‐Propelled Asymmetrical Nanomotor for Self‐Reported Gas TherapyLudan Yue, Ruibing Wang, Kuikun Yang et al.|Small|2021Cited by 45